We isolated three Escherichia coli catabolite gene activator protein mutants that are defective in the positive control of transcription initiation from the lac operon promoter region yet retain negative control of transcription from other promoters. One mutant has a substitution of valine for glutamate at residue 72, which lies in the cyclic AMP binding domain and contacts cyclic AMP. The other two mutants have substitutions of asparagine and cysteine for glycine 162, which lies in a surface-exposed turn of the DNA-binding domain. Surprisingly, although all three mutants can repress the lacP2IP3 promoters through the catabolite gene activator protein target site of lac, none displays strong dominance over the ability of wild-type catabolite gene activator protein to stimulate the lacPl promoter.
The Escherichia coli catabolite gene activator protein (CAP; also known as CRP) is a small DNA-binding protein that is responsible for global regulation of carbon utilization (reviewed in reference 9). When it forms a complex with cyclic AMP (cAMP), CAP binds to DNA target sites at or near numerous promoters in the chromosome, stimulating (positively controlling) transcription initiation from some promoters, e.g., lacPJ, galPI, and malT, and inhibiting (negatively controlling) initiation from others, e.g., galP2 (19) and lacP2IP3 (31) .
In several cases, clusters of overlapping promoters are controlled through a single CAP-cAMP target site. For example, there are three sites that bind RNA polymerase and direct transcription of the lac operon in vitro and in vivo (10, 31) . Transcription from lacP2 and lacP3 is initiated 22 and 15 bp, respectively, upstream of the lacPJ transcription start point, and all three promoters are regulated through the same CAP-cAMP target site. lacP2 and lacP3 are weak promoters and are moderately repressible by CAP-cAMP. In contrast, lacPJ is greatly stimulated by CAP-cAMP, transforming it from a weak promoter into a strong one. Similarly, the galPI and galP2 promoters are closely spaced and regulated through a common CAP-cAMP site.
At a molecular level, there are several ways in which CAP might stimulate transcription. For example, when CAPcAMP binds to DNA it bends it sharply (30) , and this may alter the circumstances under which RNA polymerase recognizes, binds to, and initiates transcription from the promoter (5, 22) . Alternatively, CAP-cAMP may directly contact RNA polymerase, as suggested by studies in which RNA polymerase stabilizes CAP-cAMP binding to the CAPcAMP target site (15, 23, 27) , and this contact may enhance one or more steps of transcription initiation.
One advantage to studying positive control of transcription by CAP is that genetic and biochemical data may be related to the X-ray crystallographic structure of the CAPcAMP complex (29) . In this structure, CAP has two domains. The N-terminal domain is responsible for dimerization and cAMP binding. The C-terminal domain includes a helix-turn-helix DNA-binding motif, typical of many proteins that recognize specific DNA sequences. Although both * Corresponding author. the cAMP-binding domain and the DNA-binding domain have been studied extensively, little is known about which regions have a direct role in stimulation of transcription.
Irwin and Ptashne (13) hypothesized that CAP-cAMP stimulates transcription via direct contact between the helixturn-helix motif and RNA polymerase. They noted structural similarities between CAP and the bacteriophage X cI repressor protein. Since changes near the helix-turn-helix DNA recognition motif of the cI repressor made it defective in positive control of the X P,rn promoter, they created CAP mutations near the helix-turn-helix motif by site-specific mutagenesis of crp, the gene which encodes CAP. They obtained two CAP mutants defective in positive control of lac transcription (CAPPC mutants) that had substitutions for glutamate 171 and reduced stimulation of lac transcription without grossly affecting binding to the lac CAP-cAMP target site.
We decided to screen for additional CAPPC mutants to identify other residues directly involved in positive control of lac. To avoid bias against any regions of CAP that are biologically relevant to positive control of lacPJ, we chose to mutagenize the entire crp gene. We reasoned that repression of transcription would reflect site-specific interaction of CAP with DNA, and thus CAPPC mutants that are specifically defective in positive control would repress transcription as well as wild-type CAP does (13) .
We constructed a strain in which we could simultaneously and independently screen the effect of mutations both on the stimulation of lacPJ by CAP-cAMP and on the repression function of CAP-cAMP. Since we were monitoring lactose fermentation to assess positive control of lacPJ activity, we chose to observe galactose fermentation to monitor negative control of the galP2 promoter. We isolated three CAPPC mutants that repressed galP2 but did not stimulate lacPJ as highly as did wild-type CAP. Since the lac CAP-cAMP target site is responsible for both stimulation of lacPJ and repression of lacP21P3, we confirmed that our CAPPC mutants could negatively control lacP2/P3 in addition to galP2. We also tested whether the mutant crp alleles on multicopy plasmids were dominant over a single-copy wild-type crp allele in the chromosome.
(A preliminary report of these data was presented at the 1989 Meeting on Molecular Genetics of Bacteria and Phages, Bacterial and viral strains. The bacterial strains used in this study and their relevant genotypes are listed in Table 1. RZ1324 [supE Nalr Rif' galPI-P2+ araD A(lac proAB) Acrp rpsLIF' lac+ zah::TnJO proA+B+] was used to screen for CAPPC mutants. It was constructed from XAC supE by first selecting for a spontaneous Nalr mutant and then selecting for a spontaneous Rif' mutant, P1 transducing to galP8-3 (which is galP-P2+) and then rpsL Acrp-bs990, and finally mating in an F' lac+ proA+B+ episome from E9002 that had been P1 transduced to zah::TnJO lac+. The genotype of XAC supE is supE araD A(lac proAB). SA598 (19) , G806 (11) , and CAG12080 (26) from Gal-Lac-colonies and transformed into RZ1324 cells to confirm that the CAPPC phenotype was linked to the plasmid. Sequence of mutant crp genes. Single-stranded DNA from versions of pRZ1311 and pRZ1312 was prepared as described above and sequenced by the dideoxy method with salt gradient gels (25) . Sequencing was performed as described in the two-step labeling and termination protocols in the kits, except that primers labeled at the 5' end with [-Y_32P] ATP (24) were used instead of labeling by [c-32P]dATP incorporation, and T7 DNA polymerase and lx KGB (24) were used in place of Sequenase and Sequenase buffer.
Fermentation phenotype. The ability of each mutant crp allele to stimulate fermentation of lactose, maltose, or galactose was determined using MacConkey indicator media supplemented with 0.2% carbon source and ampicillin (100 ,ug/ml).
,B-Galactosidase assays. ,-Galactosidase assays were performed in quadruplicate as described previously (18) with sodium dodecyl sulfate and chloroform (14) . Cells were grown at 30°C in LB supplemented with ampicillin (100 ,ug/ml) and isopropyl-,-D-thiogalactopyranoside (100 p,M).
All assays of crp alleles in a given strain were performed on the same day with the same growth medium and reagents. Assays in strains RZ1331 and RZ1336 were performed on the same day. Since lacPJ is so strong, assays of Lac' cells reflect lacPJ activity almost entirely; therefore, use of RZ1331 to assess lacPJ activity is warranted.
CAP quantitation. To estimate the in vivo concentration of CAP in the cultures used for ,-galactosidase assays, Western immunoblots were performed as described previously (24) , except that 20 mM Tris-HCI (pH 7.5)-150 mM NaCl-1% bovine serum albumin was used as the blocking and antibody-binding buffer. The membranes were probed with monoclonal anti-CAP antibody 64B4 (15), probed with goat anti-mouse alkaline phosphatase conjugate, and developed as described previously (24) .
RESULTS
Isolation of CAPP' mutants. Plasmid pRZ1300A bears a clone of the crp gene. Phagemid particles produced from pRZ1300A were mutagenized with UV light and infected into RZ1324 cells, and the resulting ampicillin-resistant colonies were screened on the indicator plates for their effect on lac and gal expression. Of 60,000 colonies screened, three bore plasmids which, in the RZ1324 background, gave the LacGal-phenotype expected for a CAPPC mutant.
Sequence of the mutations. The entire region of each mutant crp allele between the first HindIll site downstream of the crp promoter and 14 bp downstream of the termination codon was sequenced; this region includes the ribosome binding site and the entire translated region. Each of the three alleles differs from the wild type in only one codon. crp-EV72 has an A-to-T transversion at the second position of codon 72, giving a glutamate-to-valine change. crp-GN162 has G-to-A transitions at both the first and second positions of codon 162, giving a glycine-to-cysteine change. crp-GC162 has a G-to-T transversion at the first position of codon 162, giving a glycine-to-cysteine change. There were no other changes in the nucleotide sequences.
Effect of CAPPC mutants on fermentation of different carbon sources. Strain RZ1331 has wild-type lac, gal, and mal fermentation phenotypes. RZ1331 was transformed with pRZ1301, pRZ1300A, pRZ1300A-EV72, pRZ1300A-GN162, or pRZ1300A-GC162, and the fermentation phenotypes for In vivo quantitation of the effect of CAPP' mutants on lac transcription. To quantitate the effect of each allele on stimulation of lacPJ and on repression of lacP21P3, strains RZ1331 and RZ1336 were each transformed with pRZ1301, pRZ1300A, pRZ1300A-EV72, pRZ1300A-GN162, or pRZ 1300A-GC162, and ,-galactosidase assays were performed.
(i) All mutants are severely defective in positive control of lacPI. Wild-type CAP stimulates transcription from lacPJ 70-to 80-fold when expressed from pRZ1300A in RZ1331 (Fig. 1A) . All three alleles have a severe effect on lacPJ, reducing stimulation to three-to sixfold. The fact that all three do stimulate lacPJ slightly, however, indicates that they do retain some ability to recognize and interact with the CAP-cAMP binding site.
(ii) Mutants negatively control lacP2/P3. The DNA target sites of CAP-cAMP in lac and gal are different. Our screen, therefore, could have yielded mutants that could repress galP2 but not lacP2IP3. Because of this, we wished to determine the extent to which the defect in the positive control of lacPJ could be explained by failure to interact with the CAP-cAMP target site of lac. Therefore, since the DNA target site that controls lacP2IP3 is the same as the site that controls lacPJ, we measured the ability of the mutants to repress the lacP2IP3 promoters in vivo. When expressed in RZ1336, wild-type CAP represses lacP21P3 threefold (Fig.  1B) . CAP-GC162 represses lacP2IP3 slightly more than the wild type does. CAP-GN162 represses lacP2IP3 slightly less than the wild type does. CAP-EV72 represses lacP2/P3 but much less than wild type does (less than twofold).
(iii) Mutant CAP is present at the same level in RZ1331 as in RZ1336. We wished to confirm for each crp allele that the effects on lacPJ and lacP21P3 reflected a response to an equal level of CAP in RZ1331 and RZ1336. To quantitate the relative levels of expression of CAP from each plasmid in RZ1331 and RZ1336, total cell protein from each of the cultures used in the ,-galactosidase assays (described above) was Western blotted with monoclonal antibody 64B4. For each of the four alleles, the quantity of CAP per cell in RZ1331 transformants was reproducibly the same as that in RZ1336 transformants (data not shown). Thus, the stimulation of lacPJ and repression of lacP21P3 reflect responses to equal levels of CAP. All strains with mutant crp alleles had about as much CAP as did strains with the wild-type allele CAPPC mutants are not strongly dominant. We reasoned that if the CAPPC mutants were defective only in positive control of transcription, then when expressed from multicopy plasmids they would be dominant over wild-type CAP expressed from the chromosome. pRZ1301, pRZ1300A, pRZ1300A-EV72, pRZ1300A-GN162, and pRZ1300A-GC162 were transformed into MG1655, a strain with a single copy of wild-type crp on the chromosome. ,B-Galactosidase assays were performed to measure the effect of the mutant CAPs on lacPJ (Fig. 2) . Each of the mutant transformants expressed less 3-galactosidase than did the wild type, but none of them reduced lac expression more than twofold relative to that of the pRZ1300A transformant. DISCUSSION To learn which domains of CAP are responsible for positive control, we have undertaken a random mutagenesis of the entire crp gene to obtain CAPPC mutations. We developed a screen for CAP alleles that are defective in positive control of lacPl yet negatively control galP2. We found three CAPPC mutants; all three negatively control both gaIP2 and lacP21P3 but are severely defective in lacPl stimulation. CAP-GC162 and wild-type CAP show the same degree of repression of lacP2/P3, whereas CAP-GN162 and CAP-EV72 show significant loss of repression. Thus our screen was effective.
Western blot results showed that the level of CAP-GC162 is the same in cells in which lacP21P3 is repressed as in cells in which lacPJ is stimulated. Thus, the decreased stimulation of lacPJ cannot be explained by underexpression of CAP-GC162 in RZ1331 relative to that in RZ1336. CAP-EV72 and CAP-GN162 are both present at the same levels in both RZ1331 and RZ1336 and are present at the same level as wild-type CAP. CAP-GC162 is present at a twofold-higher level than is wild-type CAP in both RZ1331 and RZ1336, suggesting that the autoregulation of the crp promoter by CAP-GC162 may be altered. The results of Okamoto and Freundlich (20, 21) indicate that autoregulation of the crp promoter is achieved by stimulation of a CAP-cAMP-dependent promoter downstream of and opposed to the crp promoter. Thus, since CAP-GC162 might be defective in the positive control of this opposed promoter as well as the lacPJ promoter, a slightly higher level of CAP-GC162 cannot be taken as direct evidence that it is a poor autoregulator because of poor DNA sequence recognition.
We tested the mutant crp alleles for dominance when present in multiple copies in a genetic background of one wild-type crp copy per cell. None of the mutants was strongly dominant. This suggests that in each case the mutant homodimers do not compete effectively with heterodimers or wild-type homodimers for the CAP-cAMPbinding site in the lac promoter region. Since Although our aim was to isolate CAP mutants that were specifically defective in the positive control of lac transcription, we found that our mutants all decreased maltose fermentation and that CAP-EV72 alone decreased gal fermentation. The fact that the range of carbon sources affected differs among our mutants, and also among those of Irwin and Ptashne (13) , is consistent with the hypothesis that there may be more than one mechanism by which catabolite sensitive operons are activated (7, 12, 16, 17) .
How might the structural data for CAP explain the effects of the mutations we obtained on lac transcription? The crystal structure data for CAP place glycine 162 in a surfaceexposed turn (Fig. 3) . The range of possible torsion angles is more extensive for glycine than for any other amino acid (8) .
(Torsion angles reflect rotation about the N-Ca and Ca-C' bonds of the polypeptide backbone. Thus, together with the peptide bond angles, these bond angles determine the shape of the polypeptide oQ-carbon backbone.) Therefore, the substitutions at position 162 could have an indirect steric effect by restricting the angles that the polypeptide backbone can assume, forcing side chains of neighboring amino acid residues out of their optimal positions. Alternatively, they could have a direct steric effect by introducing a side chain into a space that is normally free for either RNA polymerase or DNA to occupy, decreasing stimulation by forcing incorrect alignment. Why does the substitution of cysteine for glycine permit CAP-GC162 to repress lacP21P3 more fully than the substitution of asparagine for glycine permits CAP-GN162 to repress it? Perhaps because the longer side chain of asparagine places even more stringent constraints on the torsion angles of an amino acid residue than a cysteine side chain does (8) . Alternatively, the asparagine side chain, which is larger than the cysteine side chain, could have a greater steric effect.
In the CAP-cAMP crystal (29) , glutamate 72 is located just past the end of 3 strand 6. Its side chain is hydrogen bonded to cAMP and forms a salt bridge with arginine 123. The substitution of this glutamate side chain by a valine side chain would disrupt both of these associations. Also, the valine side chain would force more stringent constraints on the torsion angles of residue 72 than does the glutamate side chain (8) . cAMP makes many intramonomeric contacts and one intermonomeric contact with CAP in the crystal. Therefore, the EV72 change could affect many aspects of the conformation of the protein. One can imagine at least two classes of conformational changes occurring in CAP in response to binding cAMP: changes that permit it to recognize and bind to DNA target sites and changes that permit it to activate transcription (some changes may do both). CAP-EV72 does affect lacP2IP3 repression, suggesting that it may affect changes of the first class. EV72 may also alter changes that fall exclusively into the second class, however. Therefore, despite their complex phenotype, this mutant and others like it may be useful in biochemically determining which changes are necessary for activation.
It has been proposed that CAP-cAMP may stimulate transcription by making direct contact with RNA polymerase (13) . If this is so, then our mutants seem unlikely to have changes at the point of contact. Since glutamate 72 is buried deep in the cAMP-binding pocket, it is not exposed at the surface. Glycine 162 is present in a surface-exposed turn. It is near the C terminus of the protein, and, since CAP bends DNA when it binds to it (30), which might restrict access of RNA polymerase to the C terminus of CAP, it seems unlikely to us that glycine 162 would be a point of direct contact. Model building studies (28) After these studies were completed we learned that Bell et al. (4) have isolated a positive control mutation that substituted leucine for histidine at residue 159, which lies in the same turn as our substitutions at 162. As with our substitutions, this substitution also would more stringently constrain the torsion angles along the ox-carbon backbone and thus might affect the structure of the C-terminal domain, possibly disrupting direct contact between CAP and RNA polymerase, either close to or distant from this turn. Bell et al. also isolated suppressors of the HL159 mutation that had substitutions of asparagine and glutamine for leucine 52. They reported that the HL159 KN52 double mutant activates gal but not lac, as do our GN162 and GC162 single mutants. As with our change at glutamate 72, the changes at residue 52 seem oddly positioned, given the location of the other changes that affect cAMP-dependent positive control of lac; however, a CAP mutant that activates transcription in a cAMP-independent fashion (CAP*) has been isolated adjacent to it (2) . Clearly the overall communication between regions of the protein is quite complex, which may complicate efforts to answer the question of which regions constitute the activation domain.
